相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway
Guangyan Zhangyuan et al.
ONCOGENE (2020)
Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma
Yadi Liao et al.
THERANOSTICS (2020)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
EMT Transition States during Tumor Progression and Metastasis
Ievgenia Pastushenko et al.
TRENDS IN CELL BIOLOGY (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
SPINK6 Promotes Metastasis of Nasopharyngeal Carcinoma via Binding and Activation of Epithelial Growth Factor Receptor
Li-Sheng Zheng et al.
CANCER RESEARCH (2017)
Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression
Xi-Meng Lin et al.
GASTROENTEROLOGY (2017)
aPKC-i/P-Sp1/Snail Signaling Induces Epithelial-Mesenchymal Transition and Immunosuppression in Cholangiocarcinoma
Yawei Qian et al.
HEPATOLOGY (2017)
CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study
Jiliang Qiu et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway
D. Ding et al.
ONCOGENE (2017)
Reduced levels of genital tract immune biomarkers in postmenopausal women: implications for HIV acquisition
Mariel Jais et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)
GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis
Qing-Hai Ye et al.
CANCER CELL (2016)
Role of epithelial to mesenchymal transition in hepatocellular carcinoma
Gianluigi Giannelli et al.
JOURNAL OF HEPATOLOGY (2016)
Elafin in Pulmonary Arterial Hypertension Beyond Targeting Elastases
Hyung J. Chun et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma
Andrew X. Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
A Functional Variant of Elafin With Improved Anti-inflammatory Activity for Pulmonary Inflammation
Donna M. Small et al.
MOLECULAR THERAPY (2015)
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
Xiaofeng Zheng et al.
NATURE (2015)
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Kari R. Fischer et al.
NATURE (2015)
Sp1 transcription factor: A long-standing target in cancer chemotherapy
Carolina Vizcaino et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors
S. I. Labidi-Galy et al.
ONCOGENE (2015)
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
Carlos L. Arteaga et al.
CANCER CELL (2014)
A Regulatory Loop Involving miR-22, Sp1, and c-Myc Modulates CD147 Expression in Breast Cancer Invasion and Metastasis
Ling-Min Kong et al.
CANCER RESEARCH (2014)
MUC15 Inhibits Dimerization of EGFR and PI3K-AKT Signaling and Is Associated With Aggressive Hepatocellular Carcinomas in Patients
Ruo-Yu Wang et al.
GASTROENTEROLOGY (2013)
Tumor metastasis: moving new biological insights into the clinic
Liling Wan et al.
NATURE MEDICINE (2013)
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
M. Angela Nieto
SCIENCE (2013)
Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer
Kelly K. Hunt et al.
BREAST CANCER RESEARCH (2013)
Targeting the ERBB family in cancer: couples therapy
Niall Tebbutt et al.
NATURE REVIEWS CANCER (2013)
Elafin selectively regulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis
Huafeng Wei et al.
GYNECOLOGIC ONCOLOGY (2012)
The WAP protein Trappin-2/Elafin: A handyman in the regulation of inflammatory and immune responses
Thomas Verrier et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma
Jian Hong et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad et al.
NATURE (2012)
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Scott Valastyan et al.
CELL (2011)
EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies
Mu-Yan Cai et al.
GUT (2011)
The Neutrophil Elastase Inhibitor Elafin Triggers Rb-Mediated Growth Arrest and Caspase-Dependent Apoptosis in Breast Cancer
Joseph A. Caruso et al.
CANCER RESEARCH (2010)
The protease inhibitor, elafin, induces p53-dependent apoptosis in human melanoma cells
Kyung Sook Yu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
The role of signaling pathways in the development and treatment of hepatocellular carcinoma
S. Whittaker et al.
ONCOGENE (2010)
Overexpression of Elafin in Ovarian Carcinoma Is Driven by Genomic Gains and Activation of the Nuclear Factor κB Pathway and Is Associated with Poor Overall Survival
Adam Clauss et al.
NEOPLASIA (2010)
Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma
Anne F. Buckley et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Molecular targeted therapies in hepatocellular carcinoma
Josep M. Llovet et al.
HEPATOLOGY (2008)
Novel innate immune functions of the whey acidic protein family
Colin D. Bingle et al.
TRENDS IN IMMUNOLOGY (2008)
Elafin prevents lipopolysaccharide-induced AP-1 and NF-κB activation via an effect on the ubiquitin-proteasome pathway
Marcus W. Butler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Proteins with whey-aicidic-protein motifs and cancer
D Bouchard et al.
LANCET ONCOLOGY (2006)
SLPI and elafin: one glove, many fingers
SE Williams et al.
CLINICAL SCIENCE (2006)
Hepatocellular carcinoma pathogenesis: from genes to environment
Paraskevi A. Farazi et al.
NATURE REVIEWS CANCER (2006)
Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma
Y Ito et al.
BRITISH JOURNAL OF CANCER (2001)
分享论文
